Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioids
1.0.0 - STU 1 United States of America flag

Data Exchange Profiles for 2022 CDC Clinical Practice Guideline for Prescribing Opioids, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cdc-opioid-cpg/ and changes regularly. See the Directory of published versions

Plain Language Summary goes here

Home

Official URL: http://hl7.org/fhir/us/cdc-opioid-cpg/ImplementationGuide/hl7.fhir.us.cdc-opioid-cpg Version: 1.0.0
IG Standards status: Trial-use Active as of 2024-11-27 Maturity Level: 3 Computable Name: CDCOpioidCPG

Summary

Defines exchange expectations for systems that implement the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain, both in terms of the data required to evaluate whether recommendations are applicable, as well as the data required to represent proposals resulting from those recommendations.

Note that the title of this implementation guide intentionally includes the version year of the CDC Clinical Practice Guideline for Prescribing Opioids to ensure that users understand exactly which version of the guidance is being supported.

Scope of Use

This implementation guide defines FHIR profiles that characterize the data elements used in the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain recommendations. The decision support logic authoring and clinical relevance of the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain is not within the scope of this implementation guide.

How to read this Guide

  1. Home & Background – Introduces the opioid crisis context and relationship to the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain.

  2. Profiles - A listing of profiles used in each recommendation and subroutine.

  3. Artifacts – Detailed definitions of every profile, extension, value set, and operation.

  4. Change History & Roadmap – Links to ballot comments and future work items.

Target Audiences

  1. EHR and HIT vendors looking to supply opioid-related data in a consistent, reusable format.

  2. Clinical decision support developers looking to retrieve complete patient context to execute the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain logic distributed in the 2022 CDC Clinical Practice Guideline for Prescribing Opioids IG.

Acknowledgements

This Implementation Guide was made possible by the thoughtful contributions of the following people and organizations:

  • Centers for Disease Control and Prevention (CDC) – clinical subject-matter expertise and reference content for the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain.

  • The Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP) - identify and develop standards for clinical decision support.

  • HL7 Clinical Decision Support Work Group – project sponsorship and ballot reconciliation.

  • Clinical Quality Framework (CQF) Initiative – source content and reference implementations from the 2022 CDC Clinical Practice Guideline for Prescribing Opioids IG.

Credits

Project Team

  • Johnathan Coleman (Security Risk Solutions)
  • Mohammad Jafari, PhD (Security Risk Solutions)
  • Kensaku Kawamoto, MD, PhD, MHS (Independent)
  • Robert McClure, MD (Independent)
  • Amber Patel (Security Risk Solutions)
  • Bryn Rhodes (Smile CDR)
  • Chris Schuler (Smile CDR)
  • Greg White (Security Risk Solutions)

Government Leadership

  • Mera Choi (ASTP)
  • Alison Kemp, MPH (ASTP)
  • Anastasia Perchem (ASTP)
  • Adam Wong, MPP (ASTP)

Dependencies

Cross Version Analysis

This is an R4 IG. None of the features it uses are changed in R4B, so it can be used as is with R4B systems. Packages for both R4 (hl7.fhir.us.cdc-opioid-cpg.r4) and R4B (hl7.fhir.us.cdc-opioid-cpg.r4b) are available.

Global Profiles

Global Profiles:

TypeSourceProfile
Encounterhl7.fhir.us.qicore#6.0.0QICore Encounter
Immunizationhl7.fhir.us.qicore#6.0.0QICore Immunization
Observationhl7.fhir.us.qicore#6.0.0QICore Simple Observation
Organizationhl7.fhir.us.qicore#6.0.0QICore Organization
Patienthl7.fhir.us.qicore#6.0.0QICore Patient
Practitionerhl7.fhir.us.qicore#6.0.0QICore Practitioner
PractitionerRolehl7.fhir.us.qicore#6.0.0QICore PractitionerRole

All resources of these types must conform to these profiles.

IP Statements

This publication includes IP covered under the following statements.

Expansion Parameters

Parameter Value
system-version SNOMED CT[US]
system-version International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)[2021]
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/ActiveCancerEncounterDiagnosisCondition|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/ActiveCancerProblemListHealthConcernCondition|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/AcutePainManagementMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/AmphetamineMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/AmphetamineMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/AmphetamineUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/BarbiturateMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/BarbiturateMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/BarbiturateUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/BenzodiazepineMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/BenzodiazepineMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/BenzodiazepineUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/BuprenorphineMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/BuprenorphineMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/BuprenorphineUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/CannabinoidUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/CNSDepressantMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/CNSDepressantMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/ChronicPainManagementMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/CocaineUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/EndOfLifeEncounterDiagnosis|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/EndOfLifeProblemsListHealthConcernCondition|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/ExtendedReleaseOpioidMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/ExtendedReleaseOpioidMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/FentanylMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/FentanylMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/FentanylUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/HeroinUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/MethadoneMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/MethadoneMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/MethadoneUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/MMEMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/NaloxoneMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/NaloxoneMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OpiateMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OpiateMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OpiateUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OpioidMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OpioidMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OpioidMisuseAssessmentProcedure|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OpioidReviewIndicatedPatientEncounter|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OpioidReviewIndicatedPatient|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OpioidReviewIndicatedPatientMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OxycodoneMedication|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OxycodoneMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/OxycodoneUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/PainManagementProcedure|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/PainTreatmentCarePlan|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/PDMPReviewObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/PDMPReviewProcedure|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/PCPUrineDrugScreeningResultObservation|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/SickleCellEncounterDiagnosisCondition|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/SickleCellProblemListHealthConcernCondition|1.0.0
default-canonical-version http://hl7.org/fhir/us/cdc-opioid-cpg/StructureDefinition/SubacutePainManagementMedicationRequest|1.0.0
default-canonical-version http://hl7.org/fhir/us/core/StructureDefinition/us-core-practitioner|6.1.0